Oscar Tellechea

Oscar Tellechea

Auto-generated profile, based on publicly available information

Oscar Tellechea

Dermatology Department Coimbra Hospital and University Centre Coimbra Portugal

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 February 2021 in Journal of Cutaneous Pathology
Verified
Journal Article
Closed access
PDF file
MBMariana Batista
Mariana Batista
RCRebeca Calado
Rebeca Calado
FGFrancisco Gil
Francisco Gil
JCJosé C. Cardoso
José C. Cardoso
OTOscar Tellechea
Oscar Tellechea
MGMargarida Gonçalo
Margarida Gonçalo

1 March 2012 in European Journal Of Dermatology
Verified
Journal Article
Closed access
PDF file
ÓTÓscar Tellechea
Óscar Tellechea
MCMariana Cravo
Mariana Cravo
ABAna Brinca
Ana Brinca
MRMargarida Robalo-Cordeiro
Margarida Robalo-Cordeiro


28 October 2022 in Australasian Journal of Dermatology
Verified
Journal Article
Open access
José CarlosJosé Carlos
José Carlos
FAFrancisca Alves
Francisca Alves
RCRebeca Calado
Rebeca Calado
MBMariana Batista
Mariana Batista
ICIsabel Marques Carreira
Isabel Marques Carreira
OTOscar Tellechea
Oscar Tellechea
Background/Objectives Low-dose X-ray radiotherapy to treat tinea capitis during childhood is a well-known risk factor for scalp basal cell carcinomas (BCCs). Post-radiotherapy BCCs are often multiple, and it has been suggested that they display more aggressive features. Our main objective was to study the clinicopathological aspects of post-radiotherapy BCCs to evaluate their biological behaviour and identify features that may differ from other BCCs. Methods We performed an observational, retrospective study assessing multiple clinical and pathological characteristics of patients with post-radiotherapy BCCs. Results We studied 96 patients with 427 post-radiotherapy scalp BCCs. Post-radiotherapy BCCs were often multiple (median of 4 lesions/patient, ranging from 1 to 54). Significant comorbidities included a high incidence of thyroid disease and meningiomas. Recurrences were observed in 23% of patients, but there may be confounding factors, such as referral bias, heterogenous treatment modalities and occurrence of new tumours due to field effect. We found a high incidence of infundibulocystic BCCs (in 14.6% of patients and corresponding to 5.4% of the total number of tumours), trichoblastomas (5.2%) and neurofibromas of the scalp (10%). Conclusions This study is consistent with the occurrence of multiple lesions (sometimes numerous) and a relatively high tendency for recurrence in post-radiotherapy BCCs, as suggested by previous studies. We also found a high incidence of the infundibulocystic variant and a higher risk of follicular tumours and neurofibromas, which suggests that radiotherapy may influence the type of differentiation of BCCs and contribute to induce neoplasms of different cell lines.